CNIPA.AI
검색으로 돌아가기
기록

NON-SEDATING DEXMEDETOMIDINE TREATMENT REGIMENS

발명심사 중
1조회수
20청구항 · 4 독립항
§ Ⅰ

개요

발명자

Vasukumar KAKUMANU; David Christian HANLEY; Frank YOCCA; Chetan Dalpatbhai LATHIA; Lavanya RAJACHANDRAN; Robert RISINGER

IPC 분류

A61K 31/4174A61K 9/A61K 9/6A61K 9/20A61K 9/70A61K 47/10A61K 47/26A61K 47/34A61K 47/38A61K 47/44A61P 25/18A61P 25/20A61P 25/36

CPC 분류

A61K31/4174A61K9/6A61K9/6A61K9/2013A61K9/2018A61K9/7007A61K9/7015A61K47/10A61K47/26A61K47/34A61K47/38A61K47/44A61P25/18A61P25/20A61P25/36

Disclosed herein are methods of administering relatively high doses of dexmedetomidine or a pharmaceutically acceptable salt thereof to a human subject, without also inducing significant sedation. The disclosed methods are particularly suitable for the treatment of agitation, especially when associated with neurodegenerative and/or neuropsychiatric diseases such as schizophrenia, bipolar illness such as bipolar disorder or mania, dementia, depression, or delirium.

원문 (중국어)

Disclosed herein are methods of administering relatively high doses of dexmedetomidine or a pharmaceutically acceptable salt thereof to a human subject, without also inducing significant sedation. The disclosed methods are particularly suitable for the treatment of agitation, especially when associated with neurodegenerative and/or neuropsychiatric diseases such as schizophrenia, bipolar illness such as bipolar disorder or mania, dementia, depression, or delirium.